LINFOMAS Y TRASPLANTES
University of Amsterdam
Ámsterdam, HolandaPublicaciones en colaboración con investigadores/as de University of Amsterdam (2)
2024
-
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Leukemia, Vol. 38, Núm. 9, pp. 1985-1991
2022
-
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Blood, Vol. 140, Núm. 21, pp. 2248-2260